Predict your next investment

CorVista Health company logo

See what CB Insights has to offer

Founded Year



Series C - III | Alive

Total Raised


Last Raised

$22.46M | 1 yr ago

About CorVista Health

CorVista Health is an eHealth company using advanced phase signal processing techniques for the purposes of identifying and assessing disease with an initial focus on coronary artery disease (CAD).

CorVista Health Headquarter Location

401 Harrison Oaks Blvd. Suite 100

Cary, North Carolina, 27519,

United States


Latest CorVista Health News

Medical Devices industry cross border venture financing deals total $1.18bn globally in Q1 2021

May 12, 2021

Copy and paste the image source into your website to display the chart. The value marked a decrease of 11.3% over the previous quarter and a drop of 6.4% when compared with the last four-quarter average, which stood at $1.26bn. Comparing cross border deals value in different regions of the globe, North America held the top position, with total announced deals worth $715.46m in the period. At the country level, the US topped the list in terms of deal value at $626.67m. In terms of volumes, North America emerged as the top region for medical devices industry cross border venture financing deals globally, followed by Europe and then Middle East and Africa. The top country in terms of cross border venture financing deals activity in Q1 2021 was the US with 25 deals, followed by Israel with ten and Canada with six. In 2021, at the end of , cross border venture financing deals worth $1.18bn were announced globally in medical devices industry, marking an increase of 9.9% year on year. Cross Border venture financing deals in medical devices industry in Q1 2021: Top deals Thematic Reports Are you worried about the pace of innovation in your industry? GlobalData's TMT Themes 2021 Report tells you everything you need to know about disruptive tech themes and which companies are best placed to help you digitally transform your business. The top five cross border venture financing deals in medical devices industry accounted for 34.4% of the overall value during Q1 2021. The combined value of the top five cross border venture financing deals stood at $405m, against the overall value of $1.18bn recorded for the quarter. The top five medical devices industry cross border venture financing deals of Q1 2021 tracked by GlobalData were: 1) Boyuan Capital, Dachen Caizhi, Junzi Capital, Orbimed Advisors, Temasek Holdings (Private), Yunfeng Capital and Zhang Kelingyi’s $100m venture financing of NewMed Medical 2) The $90m venture financing of Hyperfine Research by Altium Capital, Axiom Associates, Colle Capital Partners, GV Management Co, Huamin Investment Management and Nextrans 3) Alumni Ventures Group, aMoon Partners, Echo Health Ventures, Khosla Ventures and Northpond Ventures’ $82m venture financing of Scipher Medicine 4) The $68m venture financing of Syapse by Ally Bridge Group and Northpond Ventures 5) Ambix Life Science Fund I and MedVenture Partners’ venture financing of CorVista Health for $65m. Verdict deals analysis methodology This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage. GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources. More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database . Related Companies

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CorVista Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CorVista Health is included in 4 Expert Collections, including Medical Devices.


Medical Devices

8,296 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Digital Health

11,293 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

CorVista Health Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CorVista Health Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.